Introduction {#Sec1}
============

Background {#Sec2}
----------

Paediatric traumatic brain injury (pTBI) is one of the most frequent neurological emergencies affecting children throughout the world: ten million injuries lead to hospitalisation or death every year \[[@CR1]\]. In the USA alone, approximately 230,000 children suffer a TBI every year, and these lead to even more severe and long-lasting neurological disabilities than those occurring in adolescents or adults \[[@CR2]\]. Despite this, there is little evidence on which to base protocols for the management of pTBI as most of the treatment algorithms are founded on experience gained in adults and adapted on the basis of subtle differences in physiology and anatomy. However, since the introduction of the 2012 guidelines, a number of studies have been published concerning especially the surgical management of adult and pTBI, the results of which can be considered for future modifications of management protocols.

Aims {#Sec3}
----

The aim of this review is to summarise and assess current methods of surgically managing pTBI, concentrating on the use of decompressive craniectomy (DC) as a means of reducing intracranial pressure (ICP) in the short term, and improving rehabilitative outcomes in the long term. Although it is still a subject considerable debate, it has been shown that DC effectively decreases ICP and its fluctuations, and may increase cerebral perfusion pressure \[[@CR3]\], it has also been shown to be more economically effective than medical management approaches such as the use of barbiturate-induced coma \[[@CR4]\]. However, its impact on the clinical outcomes of TBI patients has yet to be fully ascertained. A systematic review was carried out with the aim of summarising the currently available evidence on the effect of the DC on ICP reduction in the short term, and rehabilitation outcomes in the long term.

This review considers the published evidence concerning the short- and long-term outcomes of DC in children pTBI, as well as the most important recent studies of its therapeutic role in adult patients.

Methods {#Sec4}
=======

Literature search {#Sec5}
-----------------

This systematic review was made following the guidelines proposed in the PRISMA statement \[[@CR5]\]. The MEDLINE and EMBASE databases were searched using the terms '(paediatric traumatic brain injury) AND (decompressive craniectomy)'. Only studies published in English were considered.

Of the 617 studies published up to October 2017, we selected the randomised clinical trials (RCTs), case series or two-arm studies that involved patients aged \< 18 years, included TBI patients who underwent DC to control ICP, and measured long-term (\> 4 weeks) outcomes. Individual case reports were excluded, as were studies that did not provide quantitative data or were designed to answer different questions (e.g. those investigating complications or outcome predictions).

Twelve of the 212 screened studies satisfied our selection criteria (one RCT, and 11 case series involving a total of 260 patients), and were read in full and analysed by all of the authors of this review. The selection process is outlined in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1PRISMA flowchart of study selection

Data analysis {#Sec6}
-------------

The extracted data included the names of the authors and the year of study publication, the number and age ranges of the patients involved, Glasgow Coma Scale (GCS) scores at the time of presentation, treatment protocols, and short- and long-term outcomes and mortality. This information was summarised and reviewed by three reviewers independently (MA, EM and AT), and further evaluated by the senior author (KT). Two of the reviewers independently assessed the quality of the data using the GRADE scoring system of the *British Medical Journal* (BMJ) \[[@CR6]\], and the risk of bias was analysed using the Cochrane risk of bias tool \[[@CR7]\].

Results {#Sec7}
=======

Quality assessment {#Sec8}
------------------

The only RCT that met the inclusion criteria \[[@CR8]\] was judged to be at risk of bias on the basis of the Cochrane risk of bias tool because of incomplete information regarding the blinding of the outcome measurer. A number of studies enrolled only a few patients, and some did not fully describe outcomes, or assess and control for confounding factors. Overall, the number of patients included in the 12 studies analysed is extremely low, varying from 5 to 53 (median 17) per study. Table [1](#Tab1){ref-type="table"} shows the level of the quality of evidence for each study on the basis of the BMJ's GRADE scoring system, and the risk of bias was assessed using RevMan \[[@CR20]\].Table 1Quality of evidence assessment for the included studiesAuthor/yearDesignNo. of patients/ageLimitationsConsistencyDirectnessOther factorsQualityCho 1995 \[[@CR9]\]Case series*n* = 17\
2--12 monthsNo serious limitationsNo important inconsistencyDirectNoneModerateThomale 2010 \[[@CR10]\]Case series (retrospective)*n* = 53\
\< 16 yearsNo serious limitationsNo important inconsistencyDirectNoneModerateTaylor 2001 \[[@CR8]\]RCT*n* = 27\
1--18 yearsNo serious limitationsNo important inconsistencyDirectNoneHighHejazi 2002 \[[@CR11]\]Case series*n* = 7\
1--18 yearsNo serious limitationsNo important inconsistencyDirectFew dataLowFigaji 2003 \[[@CR12]\]Case series*n* = 5\
5--12 yearsLimitationsNo important inconsistencyDirectFew dataLowRuf 2003 \[[@CR13]\]Case series*n* = 6\
5--11 yearsNo serious limitationsNo important inconsistencyDirectNoneModerateJosan 2006 \[[@CR14]\]Case series (retrospective)*n* = 12\
2--16 yearsNo serious limitationsNo important inconsistencyDirectLimited number of participantsModerateKan 2006 \[[@CR15]\]Case series*n* = 51\
4 months--14 yearsNo serious limitationsNo important inconsistencyDirectImprecise dataLowRutigliano 2006 \[[@CR16]\]Case series*n* = 6\
12--15 yearsNo serious limitationsNo important inconsistencyDirectLimited number of participantsModerateSkoglund 2006 \[[@CR17]\]Case series (retrospective)*n* = 19\
7--16 yearsNo serious limitationsNo important inconsistencySome uncertainty about directnessHigh risk of reporting biasLowJagannathan 2007 \[[@CR18]\]Case series (retrospective)*n* = 23\
2--19 yearsNo serious limitationsNo important inconsistencyDirectHigh risk of reporting biasLowGuresir 2012 \[[@CR19]\]Case series*n* = 34\
0--18 yearsNo serious limitationsNo important inconsistencySome uncertainty about directnessImprecise dataVery low

Effect of DC on ICP {#Sec9}
-------------------

Of the 12 studies reviewed, nine included ICP as a short-term outcome. All nine reported that ICP was successfully reduced by DC and that the patients required fewer ICP control interventions. Two studies directly compared ICP control in patients receiving medical treatment (MT) and those undergoing DC. Cho et al. \[[@CR9]\] found an 80% reduction in ICP in DC patients, which was greater than that observed in the MT group (*p* \< 0.05), and the RCT by Taylor et al. \[[@CR8]\] also found that DC led to better ICP control than MT, although the difference was not statistically significant (*p* = 0.057). The rates of ICP control achieved in all of the other studies \[[@CR10], [@CR12]--[@CR16], [@CR18]\] ranged from 69.4 to 100% (Table [2](#Tab2){ref-type="table"}).Table 2Characteristics and outcomes of included studiesAuthor /yearStudyNo. of patients/ageTreatmentOutcome measuresICP resultsFunctional outcomeCho 1995 \[[@CR9]\]Case series*n* = 17\
2--12 monthsICP \> 30 mmHg treated with DC, *n* = 10 (unilateral or bilateral)\
MT, *n* = 7ICP\
Mortality\
6-month 6-year COS80% reduction with DC (*p* \< 0.05)Mortality lower in DC group (0/10 vs 3/7; *p* \< 0.05)Better 6-month 6-year COS in DC group (*p* \< 0.05)Hearing preservation higher in DC group (*p* \< 0.05)Thomale 2010 \[[@CR10]\]Case series (retrospective)*n* = 53\
\< 16 years\
Median GCS = 6.5 in DC group and 3 in MT groupSevere TBI patients presenting at the author's centre, 14 DC and 39 MTICU stay\
ICP\
GOSICP control achieved in all DC patients. No report on ICP in MT patientsNo significant difference in 12-month and long-term GOSTaylor 2001 \[[@CR8]\]Retrospective controlled trial*n* = 27\
1--18 yearsIf high ICP, randomised to early DC (bitemporal craniectomy) or MTICP\
CPP\
ICU stay\
6-month GOSBetter control with DC (*p* = 0.057)6-month GOS 'favourable' in 14% of MT group vs 54% of DC group (*p* = 0.048)Hejazi 2002 \[[@CR11]\]Case series*n* = 7\
1--18 yearsDC if herniation or decorticate posturing (unilateral DC)5-week GCSN/AAll had GCS 15 after 5 weeksFigaji 2003 \[[@CR12]\]Case series*n* = 5\
5--12 years\
Mean GCS 4.6 (3--9)DC if GCS \< 8 (unilateral with duraplasty floating flap)ICP GOSFull ICP control in 2 and moderate reduction of ICP in 2All patients had GOS 4--5 at time of follow-up (14--40 months)Ruf 2003 \[[@CR13]\]Case series*n* = 6\
5--11 yearsDC performed in patients with ICP \> 20 mmHg for \> 30 minICP\
6-month survival and 6-month neuro-logical follow-upICP normalised immediately in all cases4 had no disability and 2 mild/moderate disabilityJosan 2006 \[[@CR14]\]Case series (retrospective)*n* = 12\
Mean GCS 6.8\
6 DC, 6 MTDC or MT in patients with refractory high ICP post-TBI\
Mean time between TBI and DC 7 hICP\
12-month GOSMean ICP after intervention 12.33 mmHg100% survival in DC group, 66% survival in MT group6 months, 100% favourable GOS in DC group vs 50% in MT groupEarly intervention (may improve outcome)Kan 2006 \[[@CR15]\]Case series*n* = 51\
4 months −14 years\
Mean GCS 4.6DCs performed at the author's institution between 1996 and 2005\
± mass lesion evacuationICP\
Mortality\
KOSCHI69.4% had normal ICP after surgical intervention31% diedMortality highest (5/6) in patients who underwent DC for ICP alone (no mass lesion)Mean follow-up KOSCHI 4.5Rutigliano 2006 \[[@CR16]\]Case series*n* = 6\
12--15 yearsDC if refractory high ICPICP\
FIMICP normalised in 5/66/6 had FIM indicating independence or minimal assistance at dischargeSkoglund 2006 \[[@CR17]\]Case series*n* = 19\
7--16 yearsDC if GCS deterioration, herniation and refractory ICP12-month GOSN/A3 patients GOS 51 patient GOS 41 patient GOS 31 patient diedJagannathan 2007 \[[@CR18]\]Case series (retrospective)*n* = 23\
2--19 yearsDCs performed at the centre between 1995 and 2006ICP\
GOS\
Likert QOL scale83% ICP controlled with DC7 died83% of the survivors returned to schoolMean follow-up GOS 4.5, median 5Guresir 2012 \[[@CR19]\]Case series*n* = 34 (23 TBI)\
0--18 yearsDC performed in 23 TBI patients, 2 SAH, 3 ICH, 5 infarction and 3 otherModified Rankin Score (favourable 0--2)\
Return to schoolN/AFavourable outcome in 40% of TBI patients30% did not return to school due to disability9th grade, 110th grade, 513th grade, 1*DC* decompressive craniectomy, *MT* medical therapy, *ICP* intracranial pressure, *ICU* intensive care unit, *GOS* Glasgow Outcome Score, *COS* Children's Outcome Score, *CPP* cerebral perfusion pressure, *FIM* Functional Independence Measure, *QOL q*uality of life, *KOSCHI* King's Outcome Scale for Closed Head Injury, *SAH* sub-arachnoid haemorrhage, *ICH* intra-cerebral haemorrhage

Effect of DC on mortality {#Sec10}
-------------------------

Only two of the studies compared mortality among the patients undergoing DC and those receiving MT. Cho et al. \[[@CR9]\] found that mortality was significantly lower in the patients who underwent DC (0/10 vs 3/7; *p* \< 0.05), and Josan et al. \[[@CR14]\] recorded higher survival rates (100% vs 66%) (Table [2](#Tab2){ref-type="table"}).

Effect of DC on long-term outcomes {#Sec11}
----------------------------------

The method of assessing long-term outcomes varied: the most widely used scoring system was the original Glasgow Outcomes Scale (GOS) or the Extended Glasgow Outcomes Scale (GOS-E), and several studies included other systems (the Functional Independence Measure, Children's Outcome Score, King's Outcome Scale for Closed Head Injury and quality of life scales). These systems generally assess functional ability and independence, return to school and performance in doing everyday activities but, given their heterogeneity, we qualitatively compared the results by dividing them into positive or negative functional outcomes. Complete recovery, or a mild disability that does not interfere with independence or activities, was regarded as a positive outcome, and severe disability, dependency, vegetative state and mortality as negative outcomes.

Ten studies reported positive outcomes in the patients who underwent DC \[[@CR8], [@CR9], [@CR11]--[@CR19]\]. Four directly compared the follow-up GOS scores of the patients who underwent DC with those of the patients receiving MT \[[@CR8]--[@CR10], [@CR14]\] (Table [2](#Tab2){ref-type="table"}). Cho et al. \[[@CR9]\] found that the scores assigned between 6 months and 6 years after a TBI were significantly better in the patients who underwent DC (*p* \< 0.05). This is in line with the results of the retrospective study of Josan et al \[[@CR14]\]: 6 months after their TBIs, all of the DC patients were assigned a favourable GOS score as against 50% of those who received MT. Taylor et al. \[[@CR8]\] also found that the DC group had a higher incidence of favourable GOS scores after 6 months (54% vs 14% in the MT group), but Thomale et al. \[[@CR10]\] did not find any significant difference in long-term GOS scores between the two groups.

Discussion {#Sec12}
==========

The use of DC to treat high ICP in paediatric and adult TBI patients has long been a subject of debate. The recommendations for surgery in children are even less clear than those included in the adult guidelines because of the severe lack of clinical evidence \[[@CR21]\]. As highlighted in this review, it has been consistently found that ICP is well controlled by DC in children with TBI in the short term, but the correlation between successful ICP control and long-term clinical outcomes is more questionable. Furthermore, the existing evidence is derived from studies with high risk of bias, and containing low patient numbers. The current guidelines \[[@CR21]\] recommend DC when performed together with other surgical procedures such as haemorrhage evacuation, or if there is strong suspicion of herniation, but its use as a stand-alone procedure to relieve ICP in patients without herniation is limited to those with intracranial hypertension (\> 25 mmHg) showing signs of neurological deterioration, or high ICP refractory to optimal MT.

The findings of the retrospective case series and the RCT reviewed generally indicate that DC has a positive effect in controlling ICP, though the quality of evidence is generally low. Hejazi's \[[@CR11]\] study reported a full recovery in five out of six patients who underwent the procedure, Figaji et al. \[[@CR12]\] similarly reported notable improvements in neurological function in a cohort of patients on whom DC was performed following neurological deterioration, and similar findings were reported by Ruf et al. \[[@CR13]\] and others. The only RCT was conducted by Taylor et al. \[[@CR8]\], who compared the outcomes of DC and MT in respectively 27 children with refractory an ICP of \> 30 mmHg and found that they were much worse in the children receiving MT. However, only two studies compare ICP control directly between patients receiving MT and those undergoing DC. Mortality was only analysed in two studies with low patient numbers \[[@CR9], [@CR14]\], of 12 and 17 respectively. More studies looked at long-term outcomes; however, outcome scales used to compare these were variable; it is therefore hard to draw general conclusions from them.

Although adult studies do not provide direct evidence concerning the paediatric use of DC, it is important to consider their results as supplementary information not least because there are more high-quality studies referring to adults. The DECRA study (decompressive craniectomy in diffuse traumatic brain injury) found that patients with refractory intracranial hypertension (\> 20 mmHg) who underwent DC required shorter ICU stays and fewer interventions to control ICP, but experienced worse long-term clinical outcomes \[[@CR22]\]. However, questions have been raised about the potential bias of this study mainly because the randomisation process led to unbalanced cohorts with discrepancies in the severity of TBI (greater in the DC group) and GCS scores upon admission; furthermore, it has been pointed out that the definition of refractory raised ICP (\> 20 mmHg for \> 15 min) does not reflect clinical practice \[[@CR23]\]. On the other hand, the RESCUE-ICP (trial of decompressive craniectomy for traumatic intracranial hypertension) trial found that the use of DC in adult patients with an ICP of \> 25 mmHg was associated with fewer deaths and cases of severe disability than medical management, although it was also associated with a higher incidence of patients experiencing a vegetative state. There was no difference in the incidence of 'good outcomes' between the two groups \[[@CR24]\]. Table [3](#Tab3){ref-type="table"} summarises the results of the most important recent studies of adults undergoing DC.Table 3Characteristics and outcomes of recent important studies in the adult populationAuthor/yearStudy type no.\
Patients\
AgeTreatmentOutcome measuresResults, outcomesStudy quality and biasCooper 2011 \[[@CR22]\]Randomised clinical trial\
*n* = 155Patients with ICP \> 20 mmHg for \> 15 min\
Randomly allocated to DC or MTICP\
6-month GOS-EICP\
DC group had fewer hours with high ICP than MT group (*p* \< 0.001)\
DC group had fewer days in ICU\
DC group had fewer ICP control interventions\
Outcomes\
DC group had worse GOS-E (OR 1.84, CI 1.05--3.24; *p* = 0.03)\
DC group at greater risk of unfavourable outcomes (death, severe disability and vegetative state), OR 2.21, CI 1.14--4.26; *p* = 0.02ICP threshold does not reflect clinical guidelines for DCMismatch in severity of TBI between DC and MT groupTimofeev 2006 \[[@CR25]\]Retrospective observational study\
*n* = 49\
Age 9--67 yearsDC, bilateral or unilateral in patients with persistently high ICP6-month GOS and SF-36 QOL questionnaireOutcomes at 6 months, 30 (61.2%) had good outcomes, 10 (20.4%) had severe disability and 9 (18.4%) diedNo comparison with untreated patientsNo randomisation or control for confoundersHutchinson 2016 \[[@CR24]\]Randomised clinical trial\
*n* = 408\
Age 10--65 yearsRefractory ICP \> 25 mmHg\
Randomly allocated to DC or MTMortality\
6-month GOSICP\
DC group had fewer hours with high ICP than MT group (*p* \< 0.001)\
Outcomes\
DC group had lower mortality rate\
MT group had lower severe disability rate\
Rates of good recovery and moderate disability were the same*DC* decompressive craniectomy, *MT* medical therapy, *ICP* intracranial pressure, *GOS* Glasgow Outcome Score

Conclusions {#Sec13}
===========

This review aims to summarise the presently available evidence in the treatment of paediatric traumatic brain injury using decompressive craniectomy versus medical treatment. The evidence considered in this review indicates a possible benefit in use of DC in patients with pTBI for reducing high ICP (\> 25 mmHg) that is refractory to medical treatment. However, the quality of evidence remains extremely low, and there is very little evidence from RCTs to indicate whether this correlates with long-term benefits in the paediatric population. The findings of retrospective studies generally indicate a beneficial effect with improved long-term neurological recovery, but they are sometimes inconsistent and their quality varies because of differences in the patient age, the criteria for and timing of surgery, injury factors, rating scales used and the use of concomitant medical treatment. Overall, though available evidence unanimously indicates a short-term benefit in using DC to reduce ICP and mortality, and possible long-term rehabilitative improvement, the assessment of evidence quality carried out highlights the lack of evidence in the field, and further high-quality studies on larger patient numbers are certainly required.
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